×
About 1,351 results

ALLMedicine™ Metastatic Bone Disease Center

Research & Reviews  639 results

What Is the Clinical Impact of Sending Tissue for Histopathology During Surgery for Kno...
https://doi.org/10.21873/anticanres.15023
Anticancer Research; Gusho CA, Blank AT

May 6th, 2021 - During surgery for patients with known, diffuse metastatic bone disease (MBD), lesional tissue is routinely sent for pathological evaluation. However, there are limited data to assess whether there is a role for histopathology for MBD despite time...

Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal...
https://doi.org/10.1097/CORR.0000000000001749
Clinical Orthopaedics and Related Research; Bozzo A, Deng J et. al.

Apr 9th, 2021 - Lung cancer is one of the most commonly diagnosed cancers and is the leading cause of cancer-related deaths. Metastatic bone disease occurs in 20% to 40% of patients with lung cancer, and these patients often present with pain or skeletal-related ...

Successful application of focused extracorporeal shockwave therapy for plantar fasciiti...
https://doi.org/10.1007/s00520-021-06117-9 10.1007/s00167-012-2009-3 10.1016/j.ultrasmedbio.2007.02.014 10.1007/s11999-013-3132-2 10.1016/j.ijsu.2017.08.587 10.1136/bjsports-2015-094695 10.3113/FAI.2008.0699 10.1016/j.maturitas.2018.10.001 10.1016/j.jgo.2014.10.003 10.1016/j.pmrj.2017.08.403 10.1016/j.apmr.2017.05.016 10.1016/j.ctrv.2017.10.006 10.1080/09638288.2018.1514665 10.1200/JCO.19.01696 10.1302/2058-5241.5.190067 10.1007/s00520-019-05046-y
Supportive Care in Cancer : Official Journal of the Multi... Zdravkovic A, Mickel M et. al.

Mar 21st, 2021 - Focused extracorporeal shock wave therapy (fESWT) has been shown to be effective in a large number of musculoskeletal disorders. Until 2016, cancer was considered a contraindication for fESWT. The goal of this Commentary is to address the subject ...

"The use of bisphosphonates to treat skeletal complications in solid tumours".
https://doi.org/10.1016/j.bone.2021.115907
Bone D'Oronzo S, Wood S et. al.

Mar 6th, 2021 - The skeleton is the most common site of secondary disease in breast cancer and prostate cancer, with up to 80% of patients with advanced disease developing bone metastases (BM). The proportion is also substantial in advanced lung cancer (20%-40%)....

Quality of life and pain in patients with metastatic bone disease from solid tumors tre...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893880
BMC Cancer; Ribi K, Thürlimann B et. al.

Feb 20th, 2021 - Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors. Knowledge of the impact of their routine care use on patient-reported pain and bone pain-related quality of life (QoL) is limited. Th...

see more →

Clinicaltrials.gov  675 results

What Is the Clinical Impact of Sending Tissue for Histopathology During Surgery for Kno...
https://doi.org/10.21873/anticanres.15023
Anticancer Research; Gusho CA, Blank AT

May 6th, 2021 - During surgery for patients with known, diffuse metastatic bone disease (MBD), lesional tissue is routinely sent for pathological evaluation. However, there are limited data to assess whether there is a role for histopathology for MBD despite time...

Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal...
https://doi.org/10.1097/CORR.0000000000001749
Clinical Orthopaedics and Related Research; Bozzo A, Deng J et. al.

Apr 9th, 2021 - Lung cancer is one of the most commonly diagnosed cancers and is the leading cause of cancer-related deaths. Metastatic bone disease occurs in 20% to 40% of patients with lung cancer, and these patients often present with pain or skeletal-related ...

Successful application of focused extracorporeal shockwave therapy for plantar fasciiti...
https://doi.org/10.1007/s00520-021-06117-9 10.1007/s00167-012-2009-3 10.1016/j.ultrasmedbio.2007.02.014 10.1007/s11999-013-3132-2 10.1016/j.ijsu.2017.08.587 10.1136/bjsports-2015-094695 10.3113/FAI.2008.0699 10.1016/j.maturitas.2018.10.001 10.1016/j.jgo.2014.10.003 10.1016/j.pmrj.2017.08.403 10.1016/j.apmr.2017.05.016 10.1016/j.ctrv.2017.10.006 10.1080/09638288.2018.1514665 10.1200/JCO.19.01696 10.1302/2058-5241.5.190067 10.1007/s00520-019-05046-y
Supportive Care in Cancer : Official Journal of the Multi... Zdravkovic A, Mickel M et. al.

Mar 21st, 2021 - Focused extracorporeal shock wave therapy (fESWT) has been shown to be effective in a large number of musculoskeletal disorders. Until 2016, cancer was considered a contraindication for fESWT. The goal of this Commentary is to address the subject ...

"The use of bisphosphonates to treat skeletal complications in solid tumours".
https://doi.org/10.1016/j.bone.2021.115907
Bone D'Oronzo S, Wood S et. al.

Mar 6th, 2021 - The skeleton is the most common site of secondary disease in breast cancer and prostate cancer, with up to 80% of patients with advanced disease developing bone metastases (BM). The proportion is also substantial in advanced lung cancer (20%-40%)....

Quality of life and pain in patients with metastatic bone disease from solid tumors tre...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893880
BMC Cancer; Ribi K, Thürlimann B et. al.

Feb 20th, 2021 - Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors. Knowledge of the impact of their routine care use on patient-reported pain and bone pain-related quality of life (QoL) is limited. Th...

see more →

News  37 results

Cancer Bone Mets Therapy: One in 40 Patients at Risk for ONJ
https://www.medscape.com/viewarticle/913958

Jun 4th, 2019 - CHICAGO — New data highlight the risk for osteonecrosis of the jaw (ONJ) in cancer patients who take bone-modifying agents to reduce the risk for skeletal events associated with bone metastases. One of the studies, S0702, was a prospective observa...

Fast Five Quiz: How Much Do You Know About Metastatic Bone Disease?
https://reference.staging.medscape.com/viewarticle/912319

May 19th, 2019 - Metastatic bone disease is a secondary cancer that occurs when cells from the primary tumor migrate to a bone location. Cell migration can occur by attachment to a basement membrane of the blood vessel wall (ie, neovascularization) or migration to...

Fast Five Quiz: How Much Do You Know About Metastatic Bone Disease?
https://reference.medscape.com/viewarticle/912319_2

May 19th, 2019 - Figure 1. Imaging of metastatic bone disease showing multiple metastases to the shoulder, ribs, pelvis, humerus, femur and spinal vertebrae. The most common location for metastatic bone disease is the spine, regardless of the primary tumor locatio...

Fast Five Quiz: How Much Do You Know About Metastatic Bone Disease?
https://reference.medscape.com/viewarticle/912319

May 19th, 2019 - Metastatic bone disease is a secondary cancer that occurs when cells from the primary tumor migrate to a bone location. Cell migration can occur by attachment to a basement membrane of the blood vessel wall (ie, neovascularization) or migration to...

Fast Five Quiz: Metastatic Bone Disease Management
https://reference.medscape.com/viewarticle/906277_2

Mar 26th, 2019 - Answer 1/5 In which of the following primary cancers does MBD most commonly occur? Your peers chose: In men, liver and kidney cancers; in women, uterine and thyroid cancers 0% In men, kidney and brain cancers; in women, liver and kidney cancers 0%...

see more →